An Analysis of 852 Prospectively-Collected Patient Samples to Evaluate the Performance of Age-Specific Videssa® Breast Protein Signatures for the Detection of Breast Cancer in the Provista 001(Ages 25-49) and Provista 002 (Ages 25-75) Studies     

Provista Diagnostics presented this poster at San Antonio Breast Cancer Symposium (SABCS) demonstrating a non-invasive, blood-based combinatorial proteomic biomarker assay (Videssa® Breast) that is to be used as an adjunct to standard-of-care imaging to detect the presence or absence of breast cancer. 

Learn more by downloading the scientific poster

HUPO-2016densebreast.png

Download Poster